Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis

Nefrologia

Volumn 27, Issue 6, 2007, Pages 710-715

  Wagrowska Danilewicz, Malgorzata ^a,b   Danilewicz, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Focal segmental glomerulosclerosis; Minimal change disease; Synaptopodin

Indexed keywords

ACTIN BINDING PROTEIN; STEROID; SYNPO PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BIOSYNTHESIS; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIPOID NEPHROSIS; MALE;

ADOLESCENT; ADULT; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; NEPHROSIS, LIPOID; STEROIDS;

EID: 42949144288     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Asanuma K, Mundel P: The role of podocytes in glomerular pathology. Clin Exp Nephrol 7(4): 255-259, 2003.
2. Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Wiliams DG: Adult-onset minimal change nephritic syndrome: a long-term follow-up. Kidney Int 29: 1215-1223, 1986.
3. Nakayama M, Katafuchi R, Yanase T, Ikeda K, Fujimi S: Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kid Dis 39(3): 503-512, 2002.
4. Fogo AB: Minimal change disease and focal segmental glomerulosclerosis. Neprol Dial Transplant 16(Supl. 6): 74-76, 2001.
5. Bertani T, Poggi A, Pozzoni R, Delaini F, Saccchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB: Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46: 16-23, 1982.
6. Endlich K, Kriz W, Witzgall R: Update in podocyte biology. Curr Opin Nephrol Hypertension 10: 331-340, 2001.
7. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P: Podocin, a raft-associated component of the glomerular slit diaphragm, interact with CD2AP and nephrin. J Clin Invest 108: 1621-1629, 2001.
8. Koop K, Eikmans M, Baelde HJ, Kawachi H, De Heer E, Paul LC, Bruijn JA: Expression of podocyte associated molecules in acquired human kidney diseases. J Am Soc Nephrol 14: 2063-2071, 2003.
9. Mundel P, Gilbert P, Kriz W: Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein. J Histochem Cytochem 39: 1047-1056, 1991.
10. Mundel P, Heid HW, Mundel TM, Kriger M, Reiser J, Kriz W: Synaptopodin: an actin-associated protein in telencephalic dendrities and renal podocytes. J Cell Biol 139: 193-204, 1997.
11. Tune BM, Mendoza SA: Treatment of idiopathic nephritic syndrome: regimens and outcomes in children and adults. J Am Soc Nephrol 8(5): 824-832, 1997.
12. Report of International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98: 561-564, 1981.
13. Churg J, Bernstein J, Glassock RJ: Renal disease. Classification and atlas of glomerular diseases. Igaku-Shoin, New York, Tokyo, pp. 45-65, 1995.
14. Weibel ER: Point counting methods In: Weibel ER, Stereological Methods Vol 1 Academic Press, London, New York, Toronto, Sydney, San Francisco, pp. 101-159, 1979.
15. Levidiotis V, Power D: New insight into molecular biology of the glomerular filtration barrier and associated disease. Nephrology 10: 157-166, 2005.
16. De Zoysa JR, Topham PS. Podocyte biology in human disease. Nephrology 10: 362-367, 2005.
17. Kawachi H, Miyauchi N, Suzuki K, Gi Dong H, Orikasa M, Shimizu F. Role of podocyte slit diaphragm as a filtration barrier. Nephrology 11: 274-281, 2006.
18. Guan N, Ding J, Zhang J, Yang J: Expression of nephrin, podocin, α-actinin, and WT1 in children with nephrotic syndrome. Pediatr Nephrol 18: 1122-1127, 2003.
19. Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M: Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome. Pol J Pathol 57(1): 17-21, 2006.
20. Asanuma K, Kim K, Oh J, Giardano L, Chabanis S, Faul C, Reiser J, Mundel P: Synaptopodin regulates the actin-bundling activity of α-actinin in an isoform-specific manner. J Clin Invest 115: 1188-1198, 2005.
21. Barisoni L, Mundel P: Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 23: 353-360, 2003.
22. Smeets B, Dijkman HBPM, Te Loeke NAJM, Van Son JPHF, Steenbergen EJ, Assmann KJM, Wetzels JFM, Groenen PJTA: Podocyte changes upon induction of albuminuria in Th-1.1 transgenic mice. Nephrol Dial Transplant 18: 2524-2533, 2003.
23. Srivastava T, Garola RE, Whiting JM, Alon US: Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int 59(1): 118-25, 2001.
24. Ostalska-Nowicka D, Zachwieja J, Nowicki M, Kaczmarek E, Siwinska A, Witt M: Vascular endothelial growth factor (VEGF-C1)-dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach. Histopathology 46: 176-183, 2005.
25. Antignac C: Molecular basis of steroid-resistant nephritic syndrome. Nefrología 25(Supl. 2): 25-28, 2005.
26. Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri GM: Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12: 2742-2746, 2001.
27. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodríguez-Pérez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24: 251-256, 2000.
28. Huber TB, Kwoh C, Wu H, Asanuma K, Godel M, Hartleben B, Blumer KJ, Miner JH, Mundel P, Shaw AS: Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. J Clin Invest 116: 1337-1345, 2006.
29. Meyrier A, Simon P: Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis. Adv Nephrol 17: 127-150, 1988.